Economic burden of varicella in singapore - A cost benefit estimate of implementation of a routine varicella vaccination

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 3, 2004, Pages 693-696

  Jean Jasmin, Lee M L ^a   Lynette, Shek Pei Chi ^a   Stefan, Ma ^b   Chew, Suok Kai ^b   Chew, F T ^a   Lee, Bee Wah ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MINISTRY OF HEALTH   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; ARTICLE; CHICKENPOX; CHILD; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; EMERGENCY WARD; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; IMMUNIZATION; INFANT; MEASLES VACCINATION; MEDICAL CARE; MUMPS; PRIMARY HEALTH CARE; PRODUCTIVITY; RUBELLA; SINGAPORE; TIME SERIES ANALYSIS; VACCINATION;

EID: 8444239009     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Asano Y. Varicella vaccine: the Japanese experience. J Infect Dis 1996: 174 (suppl 3): S310-3.
2. Beutels P, Clara R, Tormans G, Van Doorslaer E. Cost benefits of a routine varicella vaccination in German children. J Infect Dis 1996; 174: S335-41.
3. Brisson M, Edmunds WJ. The cost effectiveness of varicella vaccination in Canada. Vaccine 2002; 20: 1113-25.
4. Chew FT, Goh DYT, Lee BW. The economic cost of asthma in Singapore. Aust NZ J Med 1999; 29: 228-33.
5. Coudeville L, Paree F, Lebrun T, Sailly J. The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France. Vaccine 1999; 17: 142-51.
6. Diez Domingo J, Ridao M, Latour J, Ballester A, Morant A. A cost benefit analysis of routine varicella vaccination in Spain. Vaccine 1999; 17: 1306-11.
7. Emmanuel SC, Tan BY, Choo KW. 1993 Morbidity survey of outpatients. Singapore Fam Physician 1994; 2: 75-91.
8. Gershon AA. Varicella: to vaccinate or not to vaccinate? Pediatrics 1994; 94: 524-6.
9. Gershon AA. Varicella vaccine: its past, present and future. Pediatr Infect Dis J 1995; 14: 742-4.
10. Holmes SJ. Review of recommendations of the Advisory Committee on Immunisation Practises, Centers for the Disease Control and Prevention, on varicella vaccine. J Infect Dis 1996; 174: S342-4.
11. Hong CY, Goh LG. Routine immunisation against chickenpox..Is it time? J Singapore Pediatr Soc 1992; 34: 57-66.
12. Huse DM, Meissner C, Lacey MJ, Oster G. Childhood vaccination against chickenpox: an analysis of benefits and costs. J Pediatr 1994; 124: 869-74.
13. Lam MS, Chew SK, Allen, DM, Monteiro EHA. Fatal varicella infections in Singapore. Singapore Med J 1993; 34: 213-5.
14. Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 1998; 3: 886-90.
15. Lieu TA, Balck SB, Reiser N, et al. The cost of childhood chickenpox: parents' perspective. Pediatr Infect Dis J 1994; 13: 173-7.
16. Lieu TA, Cochi SL, Black SB, et al. Cost effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375-81.
17. Ooi PL, Goh KT, Doraisingham S, Ling AE. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J Trop Med Public Health 1992; 23: 25.
18. Preblud SR. Varicella: complications and costs. Pediatrics 1988; 78: 735-8.
19. Quarantine and Epidemiology Department, Ministry of Environment, Singapore. Communicable Disease Surveillance in Singapore 1994-97.
20. Ross RN. The cost of managing asthma. J Respir Dis 1988; 21 (suppl): S15-S20.
21. Scuffham PA, Lowin AV, Burgess MA. The cost effectiveness of varicella vaccine programs in Australia. Vaccine 1999; 18: 407-15.
22. Smith KJ, Roberts MS. Cost effectiveness of vaccination strategies in adults without a history of chickenpox. Am J Med 2000; 108: 723-9.
23. rd International Congress of Pediatrics. 2001: 1-116.
24. Weller TH. Varicella: historical perspective and clinical overview. J Infect Dis 1996; 174 (suppl 3): S306-9.